Semaglutide studies: 1,194 papers with results
Page 9 of 24
- Microvascular Benefits of New Antidiabetic Agents: A Systematic Review and Network Meta-Analysis of Kidney Outcomes.
Cha AS · The Journal of clinical endocrinology and metabolism · 2021
Systematic review · 2 results
- Clinical Advances in Heart Failure with Preserved Ejection Fraction: A Systematic Review of Therapeutic and Mechanistic Evidence.
Parizad R · Vascular health and risk management · 2026
Systematic review · 8 results
- Does semaglutide increase the risk of non-arteritic anterior ischemic optic neuropathy? A systematic review and meta-analysis of emerging evidence.
Chen KY · Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) · 2026
Systematic review · 6 results
- Impact of GLP-1 Receptor Agonists on Suicide Behavior: A Meta-Analysis Based on Randomized Controlled Trials.
Chen J · Journal of diabetes · 2025
Systematic review · 4 results
- The effects of non-insulin anti-diabetic medications on the diabetic microvascular complications: a systematic review and meta-analysis of randomized clinical trials.
Wen S · BMC endocrine disorders · 2025
Systematic review · 4 results
- Impact of semaglutide on lipid profiles in overweight and obese non-diabetic adults: A systematic review and meta-analysis of randomized controlled trials.
Miranda S · European journal of pharmacology · 2025
Systematic review · 5 results
- Gastrointestinal safety of semaglutide and tirzepatide vs. placebo in obese individuals without diabetes: a systematic review and meta analysis.
Safwan M · Annals of Saudi medicine · 2025
Systematic review · 9 results
- Efficacy and Safety of Oral Semaglutide in the Treatment of Type 2 Diabetes: A Meta-Analysis.
Zhang L · Journal of clinical pharmacology · 2024
Systematic review · 15 results
- Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review.
Ruan Z · Expert review of clinical pharmacology · 2023
Systematic review · 2 results
- Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials.
Guo J · Frontiers in pharmacology · 2025
Systematic review · 3 results
- Comparison of glucagon-like peptide-1 receptor agonists vs. placebo on any cardiovascular events in overweight or obese non-diabetic patients: a systematic review and meta-analysis.
Kelkar R · Frontiers in cardiovascular medicine · 2024
Systematic review · 2 results
- Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Review and Network Meta-analysis for the American College of Physicians.
Damen JAA · Annals of internal medicine · 2026
Systematic review · 6 results
- GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling.
Gupta AK · Science progress · 2026
Systematic review · 19 results
- Weight Loss as a Determinant of Histological Improvement in Metabolic Dysfunction-Associated Steatotic Liver Disease in People With Obesity. A Systematic Review and Network Meta-Analysis of Randomised Clinical Trials.
Monami M · Diabetes, obesity & metabolism · 2026
Systematic review · 2 results
- Assessing the shadows: A meta-analysis of GLP-1 agonists and suicidal ideation.
Alansari AO · Medicine · 2025
Systematic review · 7 results
- Efficacy of Oral Medication in Weight Loss Management: A Systematic Review and Network Meta-Analysis.
Benedictus B · Clinical therapeutics · 2025
Systematic review · 3 results
- Semaglutide and the Risk of Nonarteritic Ischemic Optic Neuropathy: A Systematic Review and Certainty of Evidence Meta-Analysis.
Abdelaal A · Ophthalmology · 2026
Systematic review · 7 results
- The effects of glucagon-like peptide-1 receptor agonists (GLP1-RAs) on alcohol-related outcomes: a systematic review and meta-analysis.
Sinha B · Addiction science & clinical practice · 2025
Systematic review · 16 results
- Comparison of the renal outcomes of novel antidiabetic agents in patients with type 2 diabetes with chronic kidney disease: A systematic review and network meta-analysis of randomized controlled trials.
Lin R · Diabetes, obesity & metabolism · 2026
Systematic review · 2 results
- Glucagon-like peptide-1 receptor agonist semaglutide through the lens of psychiatry: a systematic review of potential benefits and risks.
Carminati M · International clinical psychopharmacology · 2026
Systematic review · 10 results
- Comparative efficacy and safety of antidiabetic drugs for obese patients with knee osteoarthritis: a network meta-analysis of randomized controlled trials.
Jiang G · Aging clinical and experimental research · 2025
Systematic review · 4 results
- The blood pressure-lowering property of subcutaneous semaglutide: a systematic review, meta-analysis, and meta-regression.
Ala M · Journal of endocrinological investigation · 2025
Systematic review · 11 results
- Safety of GLP-1 and Dual GLP-1/GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes.
Ozbek L · Diabetes, obesity & metabolism · 2026
Systematic review · 6 results
- Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Eisa N · Diabetes, obesity & metabolism · 2026
Systematic review · 5 results
- Beyond GLP-1: efficacy and safety of dual and triple incretin agonists in personalized type 2 diabetes care-a systematic review and network meta-analysis.
Yan K · Acta diabetologica · 2025
Systematic review · 5 results
- Association of long-term weight management pharmacotherapy with multiple health outcomes: an umbrella review and evidence map.
Lu TT · International journal of obesity (2005) · 2025
Systematic review · 35 results
- Clinical Efficacy and Safety of Anti-Obesity Medications Among Adult East Asian People with Obesity: A Systematic Literature Review and Indirect Treatment Comparison.
Yokote K · Advances in therapy · 2024
Systematic review · 6 results
- Gastrointestinal safety evaluation of semaglutide for the treatment of type 2 diabetes mellitus: A meta-analysis.
Huang X · Medicine · 2024
Systematic review · 5 results
- Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.
Nong K · BMJ (Clinical research ed.) · 2026
Systematic review · 29 results
- Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta-Analysis of Randomized Clinical Trials.
Hamarsheh S · Endocrinology, diabetes & metabolism · 2026
Systematic review · 14 results
- GLP-1 Receptor/Dual Agonists for Weight Loss: A Systematic Review and Network Meta-Analysis of RCTs.
Vienghirun J · Diabetes, obesity & metabolism · 2026
Systematic review · 20 results
- Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping Review.
Rico-Fontalvo J · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
Systematic review · 9 results
- GLP1-1RAs improve walking distance and reduce amputation in people with type 2 diabetes and peripheral artery disease: A systematic review and meta-analysis of randomised controlled trials and cohort studies.
Giugliano D · Diabetes, obesity & metabolism · 2026
Systematic review · 9 results
- Exploring the rates of Gastrointestinal adverse effects among five GLP-1 receptor agonists: A systematic review and Meta-Analysis of randomized controlled trials.
Joy B · Endocrine · 2026
Systematic review · 16 results
- Effectiveness of GLP-1 RAs and SGLT2 inhibitors in preventing T2DM in high-risk patients: an updated systematic review and meta-analysis.
Tsironikos GI · Frontiers in clinical diabetes and healthcare · 2025
Systematic review · 17 results
- Quantitative analysis of the efficacy characteristics and influencing factors of weight loss drugs in children and adolescents.
Wang Y · Diabetes, obesity & metabolism · 2025
Systematic review · 12 results
- Evaluation of three mechanisms of action (SGLT2 inhibitors, GLP-1 receptor agonists, and sulfonylureas) in treating type 2 diabetes with heart failure: a systematic review and network meta-analysis of RCTs.
Gao H · Frontiers in endocrinology · 2025
Systematic review · 1 result
- Efficacy and Safety of GLP-1 Receptor Agonists on Combined Cardiovascular and Renal Outcomes in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Kaur R · Diabetes, obesity & metabolism · 2026
Systematic review · 7 results
- Pharmacotherapy for Children and Adolescents With Overweight or Obesity: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Luo L · Diabetes, obesity & metabolism · 2026
Systematic review · 7 results
- Comparative Effects of Antidiabetic Drugs on Body Composition: A Systematic Review and Network Meta-Analysis.
Rakhsha SS · Diabetes, obesity & metabolism · 2026
Systematic review · 6 results
- The Impact of GLP-1-Based Therapies on Cardiovascular Outcomes in Type 2 Diabetes: A Comprehensive Systematic Review and Network Meta-Analysis.
Chuang SM · Diabetes, obesity & metabolism · 2026
Systematic review · 4 results
- Weight Loss With GLP-1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta-Analysis.
Lim M · Obesity (Silver Spring, Md.) · 2026
Systematic review · 9 results
- Relative Efficacy of Next-Generation Incretin Therapies for Cardio-Renal Protection in Type 2 Diabetes: Evidence From a Network Meta-Analysis.
Pham TP · Diabetes, obesity & metabolism · 2026
Systematic review · 5 results
- A Systematic Review and Meta-Analysis of Semaglutide Effects on Adipose Tissue and Emerging Effects on Brain and Cognition.
Saghazadeh A · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
Systematic review · 3 results
- Dose-Escalation Regimens for Incretin Mimetics in Type 2 Diabetes Are Associated With Tolerance for Nausea and Vomiting.
Nauck MA · Diabetes, obesity & metabolism · 2026
Systematic review · 10 results
- Head-to-head comparison of tirzepatide and semaglutide for weight loss: A systematic review and meta-analysis.
Zufry H · Obesity research & clinical practice · 2026
Systematic review · 12 results
- GLP-1 receptor agonists and smoking cessation: therapeutic promise beyond glycemia.
Bhaduri G · Endocrine · 2026
Systematic review · 1 result
- Effect of glucagon-like peptide-1 receptor agonists on heart rate in non-diabetic individuals with overweight or obesity: a systematic review and pairwise and network meta-analysis of randomized controlled trials.
Zhang Y · European journal of medical research · 2026
Systematic review · 10 results
- Effectiveness of GLP-1 RAs in Restoring Normoglycemia in Patients With Prediabetes: An Updated Systematic Review and Meta-Analysis.
Tsironikos GI · Diabetes/metabolism research and reviews · 2026
Systematic review · 15 results
- Effects of Semaglutide and Tirzepatide on Recurrent Weight Gain After Bariatric Surgery: A Systematic Review and Meta-analysis.
Osorio Manyari AA · Obesity surgery · 2025
Systematic review · 2 results